Purchase Order 75N95025P00273

Award Date 9/9/25
Potential Completion Date 12/9/25
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Neuronexus Technologies, Inc., doing business as Nuvectra. The $23,736.41 contract is for the administrative de-obligation of unexpended and expiring Fiscal Year 2020 funding in preparation for the September 30, 2025 closing of the period of availability for these funds, as required by 31 U.S.C. Section 1552(a). The contract is for the...
Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for the customization of software, hardware, and probe modification to enable implantation into rat brains and neural recordings in support of NIDA's biomedical research mission. Performance will...
Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to customize software, hardware, and probes for use in implanting devices into rat brains and conducting neural recordings. The contract supports research being conducted by Dr. Schoenbaum at the National Institute on Drug Abuse, part of the Department of Health and Human Services, to advance understanding of...
Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a firm fixed price purchase order valued at twenty-five thousand dollars by the National Institutes of Health's National Institute on Drug Abuse. Under this contract, Nuvectra will customize software, hardware, and neural probes for implanting into rat brains and conducting neural recordings over a one year period ending in September 2024. The goal of this work supports the National Institute on Drug Abuse's broader...
This federal contract award from the National Institute of Environmental Health Sciences (NIEHS) is for the procurement of MICROELECTRODE products from Neuronexus Technologies, Inc., doing business as Nuvectra. The $32,685.89 firm fixed-price purchase order contract does not have a set-aside designation. Neuronexus Technologies, a for-profit manufacturer of advanced neuroscience research equipment, has been awarded this contract to provide specialized neural interface products, including...
Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $75,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for Nuvectra to provide an X-DAQ ONE Series electrophysiology recording system, including hardware, software, and silicon recording probes, to support NIDA's biomedical research efforts. Performance...
The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,978.26 firm fixed price purchase order to Neuronexus Technologies, Inc., doing business as Nuvectra, for data acquisition printed circuit boards to support scientific research. The contract has a period of performance of September 7, 2023 through September 6, 2024. Place of performance will be Nuvectra's facilities in Baltimore, Maryland. No set aside designation or...
Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institute on Drug Abuse, a component of the National Institutes of Health within the Department of Health and Human Services. Under the contract, Nuvectra will provide Microelectrode PCB Adaptors and Passive Commutators to support scientific research. The adaptors and commutators will facilitate HDMI and UHDMI connections for use with X-Series equipment....
Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for Nuvectra to provide customization of software to support NIDA's research efforts. Work will be performed in Baltimore, Maryland over a one-year period concluding in September 2024. No subcontractors...
This is a $24,500 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to Plexon, Inc., a for-profit manufacturer of neuroscience research equipment. The award is for the provision of custom headstages to support NIDA's biomedical research programs. Plexon, a registered federal vendor since 2002, specializes in providing advanced neural data acquisition systems, electrodes, probes, and...

This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Neuronexus Technologies, Inc., doing business as Nuvectra. The purpose of this $24,999.00 contract is to procure neural recording probes from Neuronexus that will be used for implanting into rat brains as part of the agency's research efforts. The contract has an ultimate completion date of December 9, 2025. Neuronexus is a for-profit manufacturer of advanced neuroscience and electrophysiology research equipment, and has a history of providing specialized products and customization services to NIDA and other NIH components through federal contract awards. This contract does not have a set-aside designation.

Generated 9/11/25, 10:52 AM